Last updated on September 2016

Tolerability Safety and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)


Brief description of study

The purpose of this study is to determine if naloxegol can be used in the treatment of opioid-induced constipation in patients with cancer and pain. This phase 4 study consists of a two week randomized double blind period followed by a two week open-label period.

Clinical Study Identifier: NCT02839889

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Russell Portenoy, MD

MJHS Institute for Innovation in Palliative Care
New York, NY United States
  Connect »

Janet Bull, MD

Hospice of Henderson County, Inc
Flat Rock, NC United States
  Connect »

Charles Wellman, MD

Hospice of the Western Reserve, Inc.
Cleveland, OH United States
  Connect »